A Non-Interventional Retrospective Study To Assess The Level Of Asthma Control Among Adults at 2 Tertiary Care Centres In Malaysia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Asthma Control Level
- Sponsor
- AstraZeneca
- Enrollment
- 398
- Locations
- 2
- Primary Endpoint
- Level of GINA-defined asthma control
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
A Non-Interventional Retrospective Study To Assess The Level Of Asthma Control Among Adults at 2 Tertiary Care Centres In Malaysia; Institute Of Respiratory Medicine (IPR) And Hospital Serdang. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of GINA-defined asthma control and the potential risk factors for uncontrolled disease in asthma patients
Detailed Description
Despite the availability of GINA global guideline on asthma management which is widely referred by health care providers in Malaysia, the control of asthma is still a critical challenge. According to National Health and Morbidity Survey 2011, the prevalence of asthma in Malaysia is at 6.3%. Based on self-rated health status, 5.5% of patients were reported to be in good health whereas 9.9% reported poor health status although medications such as inhaled corticosteroids (ICS) and long-acting beta agonists (LABA) are widely available for effective asthma management. There is limited data to assess the level of asthma control in Malaysia which includes current clinical manifestation and future risk of exacerbation. Given the lack of data on Asthma control level, the awareness on the current disease control level will assist to properly characterise the patients based on GINA control level thus leading to appropriate diagnosis and treatment. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of GINA-defined asthma control and the potential risk factors for uncontrolled disease in asthma patients
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with GINA-defined clinical diagnosis of Asthma seen at respiratory clinic from January to August
- •Be at least 18 years of age
Exclusion Criteria
- •Clinical features suggesting emphysema or chronic bronchitis
- •Other de-compensated organ failures
Outcomes
Primary Outcomes
Level of GINA-defined asthma control
Time Frame: up to 8 months
To assess, in real-life clinical practice in Malaysia, the level of GINA-defined asthma control and the potential risk factors for uncontrolled disease in asthma patients
Secondary Outcomes
- Types of medication prescribed for asthma control(up to 8 months)
- Asthma control level(up to 8 months)